A detailed history of Corton Capital Inc. transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 32,366 shares of GLUE stock, worth $219,441. This represents 0.13% of its overall portfolio holdings.

Number of Shares
32,366
Holding current value
$219,441
% of portfolio
0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$4.8 - $10.36 $155,356 - $335,311
32,366 New
32,366 $224,000
Q3 2023

Nov 14, 2023

BUY
$4.78 - $7.22 $69,118 - $104,401
14,460 New
14,460 $69,000

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $317M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.